From an investor's point of view, the potential for something to be brewing in the Philippines is great news. From a personal point of view, I wish the the FDA in the US had looked deeper into our M/M results and extrapolated how the NEWS2 score would be worth EUA, or at the very least, continue with EIND's. I've got 3 familit members battling Covid as we speak. My Dad, and two aunts (two of which have underlying medical conditions) have had it for 11 days. They are all over 70 years old, all live in the same home, and have been extremely diligent to protect themselves the last 9 months. My Dad thinks he got it from the hospital when he got his pacemaker replaced about 3 weeks ago. At any rate, they all have it now, and there's not a damn thing I can do about it, when it comes to recommending leronlimab. They live in New Orleans, and there isn't even a trial site close by. This is by far the closest that I've personally been touched by Covid. It's really a helpless feeling, especially knowing that I'm part owner of a company that has a molecule that could save them right now, but it's not available to them!